Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks Sponsor : Eli Lilly and Company Recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks Sponsor : Eli Lilly and Company Recruiting - verified August 2011

Condition : Arthritis, Psoriatic Interventions : Drug: RO5310074; Drug: Placebo Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Arthropathy of Knee Joint Interventions : Procedure: PC-FNB with basal administration of local anesthetics; Procedure: PC-FNB without basal local anesthetics Sponsor : Okayama University R...

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 2 weeks; Drug: Placebo every 4 weeks Sponsor : Eli Lilly and Company Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 2 weeks; Drug: Placebo every 4 weeks Sponsor : Eli Lilly and Company Recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Drug: fostamatinib; Drug: fostamatinib; Drug: placebo Sponsor : AstraZeneca Recruiting - verified August 2011

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Osteoarthritis Intervention : Biological: Mesenchymal Injection Sponsor : Royan Institute Completed - verified April 2009

Conditions : Arthritis, Rheumatoid; Pain; Fatigue Interventions : Drug: adalimumab; Drug: Placebo Sponsors : Karolinska Institutet; Abbott; Swedish Foundation for Strategic Research; The Swedish Resea...